title: Semi-synthetic strategies to obtain glucosylated MOG to identify antibodies as biomarkers in multiple sclerosis disease.
authors.affiliation: Department of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino, FL, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Gori
authors.forename: Barbara
authors.initials: B
authors.lastname: Mulinacci
authors.forename: Eva
authors.initials: E
authors.lastname: Bonchi
authors.forename: Mario
authors.initials: M
authors.lastname: Chelli
authors.forename: Francesco
authors.initials: F
authors.lastname: Lolli
authors.forename: Anna M
authors.initials: AM
authors.lastname: Papini
authors.forename: Paolo
authors.initials: P
authors.lastname: Rovero
mesh_terms: D000906:Antibodies / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis*; D018360:Crystallography, X-Ray; D004797:Enzyme-Linked Immunosorbent Assay; D006031:Glycosylation; D006801:Humans; D009103:Multiple Sclerosis / Q000276:immunology*; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000138:chemical synthesis* / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein
chemical_list: D000906:Antibodies; D015415:Biomarkers; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein